Eating fish may lower the risk of developing MS

26th April 2018

US study shows people who eat fish may be less likely to develop MS.

Mood and anxiety disorders linked to disability progression in MS

26th April 2018

New research shows psychiatric disorders are associated with the worsening of MS disability outcomes.

Interim AHSCT trial results released

26th April 2018

Interim results from one of the first randomised controlled trials comparing autologous haematopoietic stem cell transplant (AHSCT) to other…

Siponimod offers hope for people with secondary progressive MS

26th April 2018

A new, international clinical trial has shown that siponimod can slow progression in people with secondary progressive…

Uruguay – Project Planning and Fundraising Consultancy Opportunity

10th April 2018

MSIF is seeking experienced Spanish-speaking consultants, preferably based in Uruguay, to provide training and mentoring in the…

UK MS Society volunteers raise awareness of MS at international event

9th April 2018

Volunteers from the UK MS Society’s English Council worked with the Rotarian Action Group for MS Awareness…

Polish MS Association launches MS peer support programme

9th April 2018

The ‘Peer to Peer’ support programme is designed to support people with MS shortly after diagnosis.

US launches ‘Whatever it Takes’ campaign for MS Awareness Week

9th April 2018

The National MS Society launched a new awareness-raising campaign during the US MS Awareness Week 2018, engaging…

Special guests to attend MSIF’s Global Networking Meetings in Amsterdam

9th April 2018

Queen Maxima of the Netherlands and two Olympic speed skaters will join delegates.

Tawasol – March 2018 issue

6th April 2018

The latest news from the Multiple Sclerosis (MS) associations in the Arab region.

Japanese study could improve understanding of autoimmune process in MS

23rd March 2018

New research indicates that miRNA, a genetic switch in the blood of people with MS, could help…

Experimental immunotherapy shows promising trial results

23rd March 2018

A new immunotherapy that re-educates the immune system has shown promising results in two early-stage clinical trials.